We are live on ! Find out more
OVID icon

Ovid Therapeutics
OVID

81 hedge funds and large institutions have $47.1M invested in Ovid Therapeutics in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

297% more capital invested

Capital invested by funds: $11.9M → $47.1M (+$35.2M)

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

14% more funds holding

Funds holding: 71 → 81 (+10)

0.35% more ownership

Funds ownership: 50.58% → 50.92% (+0.35%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

29% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 24

34% less call options, than puts

Call options by funds: $299K | Put options by funds: $456K

Holders
81
Holders Change
+10
Holders Change %
+14.08%
% of All Funds
1.06%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
25
Increased
17
Reduced
24
Closed
14
Calls
$299K
Puts
$456K
Net Calls
-$157K
Net Calls Change
-$162K

Top Buyers

1
AAA
Affinity Asset Advisors
New York
+$1.72M
2
IC
Ikarian Capital
Texas
+$950K
3
SSA
Schonfeld Strategic Advisors
New York
+$765K
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$542K
5
Marshall Wace
Marshall Wace
United Kingdom
+$536K

Top Sellers

1
BI
BVF Inc
California
-$1.27M
2
SCM
Sio Capital Management
New York
-$697K
3
BlackRock
BlackRock
New York
-$657K
4
TA
TLS Advisors
Florida
-$574K
5
MAP
Madison Avenue Partners
New York
-$433K
Name Holding Trade Value Shares
Change 		Change in
Stake
AAP
76
Arax Advisory Partners
Colorado
$182 +$121 +140 New
Barclays
77
Barclays
United Kingdom
$92 – – –
TWC
78
TD Waterhouse Canada
Ontario, Canada
$41 – – –
SIS
79
Sound Income Strategies
Florida
$10 – – –
Osaic Holdings
80
Osaic Holdings
Arizona
$6 – – –
BI
81
BVF Inc
California
– -$1.27M -3,853,818 Closed
MAP
82
Madison Avenue Partners
New York
– -$433K -1,311,362 Closed
RA
83
Rosalind Advisors
Ontario, Canada
– -$165K -500,000 Closed
RCMNY
84
Rubric Capital Management (New York)
New York
– -$158K -478,533 Closed
YIH
85
Y-Intercept (HK)
Hong Kong
– -$52.9K -160,306 Closed
HF
86
HRT Financial
New York
– -$40K -123,316 Closed
HSBC Holdings
87
HSBC Holdings
United Kingdom
– -$6.01K -19,220 Closed
NDSI
88
Newman Dignan & Sheerar Inc
Rhode Island
– -$5.45K -16,522 Closed
AQR Capital Management
89
AQR Capital Management
Connecticut
– -$5.18K -15,705 Closed
PI
90
PFG Investments
New York
– -$4.61K -13,975 Closed
JF
91
Jump Financial
Illinois
– -$4.53K -13,718 Closed
VF
92
Virtu Financial
New York
– -$4K -12,664 Closed
Carson Wealth (CWM LLC)
93
Carson Wealth (CWM LLC)
Nebraska
– -$1.28K -1,483 -98%
EWA
94
EverSource Wealth Advisors
Alabama
– -$8 -24 Closed
TWD
95
True Wealth Design
Ohio
– -$3 -8 Closed
1 2 3
4

OVID Hedge Fund Activity: Q3 2025 in Review

81 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Ovid Therapeutics (OVID) for Q3 2025, worth a combined $47.1M — up 297% from $11.9M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new OVID positions and 14 closed out — a net gain of 11 holders — while 17 added to existing stakes and 24 trimmed.

The largest buyer was Affinity Asset Advisors, adding an estimated $1.72M. The largest seller was BVF Inc, exiting entirely with an estimated $1.27M sold.

  • 81 institutional investors held Ovid Therapeutics (OVID) as of Q3 2025, up from 71 in Q2 2025.
  • Funds reported $47.1M of Ovid Therapeutics stock for Q3 2025, up 297% quarter-over-quarter.
  • 25 funds opened new Ovid Therapeutics positions in Q3 2025 and 14 closed out, a net change of +11 holders.
  • The largest Ovid Therapeutics buyer in Q3 2025 was Affinity Asset Advisors, an estimated $1.72M added.
  • The largest Ovid Therapeutics seller in Q3 2025 was BVF Inc, an estimated $1.27M sold.

Based on aggregated 13F filings for Q3 2025.